FDA Clarifies Informal Feedback Process Prior to Marketing Decisions

The FDA used a Q&A format to issue final guidance on an informal, non-binding process for sponsors to obtain preliminary feedback before submitting marketing applications.
Source: International Pharmaceutical Regulatory Monitor